Patient-derived tumour xenografts as models for breast cancer drug development-Reference-Cited by-同舟云学术

Patient-derived tumour xenografts as models for breast cancer drug development

Published:2014-11 Issue:6 Volume:26 Page:556-561
ISSN:1040-8746
Container-title:Current Opinion in Oncology
language:en
Short-container-title:

Author:

Marangoni Elisabetta,Poupon Marie-France

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference43 articles.

1. Global cancer statistics.;Jemal;CA Cancer J Clin,2011

2. Patient-derived tumour xenografts as models for oncology drug development.;Tentler;Nat Rev Clin Oncol,2012

3. Contributions of human tumor xenografts to anticancer drug development.;Sausville;Cancer Res,2006

4. Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models.;Voskoglou-Nomikos;Clin Cancer Res,2003

5. Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anticancer drug resistance.;Gillet;Proc Natl Acad Sci U S A,2011

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety of dalpiciclib, a cyclin-dependent kinase 4/6 inhibitor, in patients with advanced head and neck mucosal melanoma harboring CDK4 amplification;BMC Medicine;2024-05-29

2. Factors associated with engraftment success of patient-derived xenografts of breast cancer;Breast Cancer Research;2024-03-21

3. Factors Associated with Engraftment Success of Patient-Derived Xenografts of Breast Cancer;2023-11-26

4. Chick Chorioallantoic Membrane as a Patient-Derived Xenograft Model for Uveal Melanoma: Imaging Modalities for Growth and Vascular Evaluation;Cancers;2023-02-24

5. Candidate therapeutic agents in a newly established triple wild‐type mucosal melanoma cell line;Cancer Communications;2022-06-04